Day One Of Theranos CEO’s Trial Sees Her Characterized As A Liar
The trial of biotech chief Elizabeth Holmes began with prosecutors framing her as a fraudster who knowingly exaggerated claims for the medical company. Scrutiny of health care VC firms, patient administrative hassles, LGBTQ+ startups, the covid relief fund and more are also in the news.